Myriad Genetics Files $250 Million Offering

Myriad Genetics

(MYGN) - Get Report

filed with the

Securities and Exchange Commission

to sell up to $250 million of securities.

The Salt Lake City company makes diagnostic equipment and develops drugs using gene analysis.

Myriad's stock closed down $2.09 Friday at $49.91.